Prognostic significance of altered expression of SDC2 and CYR61 in esophageal squamous cell carcinoma

Oncology Reports

Volumn 21, Issue 4, 2009, Pages 1123-1129

  Huang, Xin ^a   Xiao, Da Wei ^a   Xu, Li Yan ^a   Zhong, Hai Jun ^a   Liao, Lian Di ^a   Xie, Ze Fen ^a   Li, En Min ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

CRY61; Esophageal squamous cell carcinoma; Quantitative real time RT PCR; SDC2; TGF signaling pathway

Indexed keywords

CYSTEINE RICH PROTEIN 61; MESSENGER RNA; REGULATOR PROTEIN; SYNDECAN 2; TRANSFORMING GROWTH FACTOR BETA; CYR61 PROTEIN, HUMAN; SDC2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; DOWNSTREAM PROCESSING; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SURVIVAL TIME; TISSUE SECTION; TUMOR VOLUME; CHEMISTRY; ESOPHAGUS TUMOR; GENETICS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CYSTEINE-RICH PROTEIN 61; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SYNDECAN-2; TRANSFORMING GROWTH FACTOR BETA;

EID: 67449095769     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000332     Document Type: Article

References (24)

1. Zhang H, Xu L, Xiao D, Xie J, Zeng H, Cai W, Niu Y, Yang Z, Shen Z and Li E: Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma. J Clin Pathol 59: 958-964, 2006.
2. Wang Y, Zhou X, Zhu H, Liu S, Zhou C, Zhang G, Xue L, Lu N, Quan L, Bai J, Zhan Q and Xu N: Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC) may promote cellular growth by activating beta-catenin/TCF pathway. Oncogene 24: 6637-6645, 2005.
3. Lu Z, Liu H, Xue L, Xu P, Gong T and Hou G: An activated Notch1 signaling pathway inhibits cell proliferation and induces apoptosis in human esophageal squamous cell carcinoma cell line EC9706. Int J Oncol 32: 643-651, 2008.
4. Noma K, Smalley KS, Lioni M, Naomoto Y, Tanaka N, El-Deiry W, King AJ, Nakagawa H and Herlyn M: The essential role of fibroblasts in esophageal squamous cell carcinoma-induced angiogenesis. Gastroenterology 134: 1981-1993, 2008.
5. Park H, Han I, Kwon HJ and Oh ES: Focal adhesion kinase regulates syndecan-2-mediated tumorigenic activity of HT1080 fibrosarcoma cells. Cancer Res 65: 9899-9905, 2005.
6. Chen L, Klass C and Woods A: Syndecan-2 regulates transforming growth factor-beta signaling. J Biol Chem 279: 15715-15718, 2004.
7. Clasper S, Vekemans S, Fiore M, Plebanski M, Wordsworth P, David G and Jackson DG: Inducible expression of the cell surface heparan sulfate proteoglycan syndecan-2 (fibroglycan) on human activated macrophages can regulate fibroblast growth factor action. J Biol Chem 274: 24113-24123, 1999.
8. Steinfeld R, Van Den Berghe H and David G: Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican. J Cell Biol 133: 405-416, 1996.
9. Modrowski D, Baslé M, Lomri A and Marie PJ: Syndecan-2 is involved in the mitogenic activity and signaling of granulocytemacrophage colony-stimulating factor in osteoblasts. J Biol Chem 275: 9178-9185, 2000.
10. Han I, Park H and Oh ES: New insights into syndecan-2 expression and tumourigenic activity in colon carcinoma cells. J Mol Histol 35: 319-326, 2004.
11. Park H, Kim Y, Lim Y, Han I and Oh ES: Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells. J Biol Chem 277: 29730-29736, 2002.
12. Gulyás M and Hjerpe A: Proteoglycans and WT1 as markers for distinguishing adenocarcinoma, epithelioid mesothelioma, and benign mesothelium. J Pathol 199: 479-487, 2003.
13. Munesue S, Yoshitomi Y, Kusano Y, Koyama Y, Nishiyama A, Nakanishi H, Miyazaki K, Ishimaru T, Miyaura S, Okayama M and Oguri K: A novel function of syndecan-2, suppression of matrix metalloproteinase-2 activation, which causes suppression of metastasis. J Biol Chem 282: 28164-28174, 2007.
14. Bartholin L, Wessner LL, Chirgwin JM and Guise TA: The human Cyr61 gene is a transcriptional target of transforming growth factor beta in cancer cells. Cancer Lett 246: 230-236, 2007.
15. Jiang WG, Watkins G, Fodstad O, Douglas-Jones A, Mokbel K and Mansel RE: Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. Endocr Relat Cancer 11: 781-791, 2004.
16. Chien W, Kumagai T, Miller CW, Desmond JC, Frank JM, Said JW and Koeffler HP: Cyr61 suppresses growth of human endometrial cancer cells. J Biol Chem 279: 53087-53096, 2004.
17. Tsai MS, Bogart DF, Castañeda JM, Li P and Lupu R: Cyr61 promotes breast tumorigenesis and cancer progression. Oncogene 21: 8178-8185, 2002.
18. Xie D, Yin D, Tong X, O'Kelly J, Mori A, Miller C, Black K, Gui D, Said JW and Koeffler HP: Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways. Cancer Res 64: 1987-1996, 2004.
19. Di Martino E, Wild CP, Rotimi O, Darnton JS, Olliver RJ and Hardie LJ: IGFBP-3 and IGFBP-10 (CYR61) up-regulation during the development of Barrett's oesophagus and associated oesophageal adenocarcinoma: potential biomarkers of disease risk. Biomarkers 11: 547-561, 2006.
20. Babic AM, Kireeva ML, Kolesnikova TV and Lau LF: CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA 95: 6355-6360, 1998.
21. Xie D, Miller CW, O'Kelly J, Nakachi K, Sakashita A, Said JW, Gornbein J and Koeffler HP: Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease. J Biol Chem 276: 14187-14194, 2001.
22. Tong X, Xie D, O'Kelly J, Miller CW, Muller-Tidow C and Koeffler HP: Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer. J Biol Chem 276: 47709-47714, 2001.
23. Maeta N, Osaki M, Shomori K, Inaba A, Kidani K, Ikeguchi M and Ito H: CYR61 downregulation correlates with tumor progression by promoting MMP-7 expression in human gastric carcinoma. Oncology 73: 118-126, 2007.
24. Beauvais DM and Rapraeger AC: Syndecans in tumor cell adhesion and signaling. Reprod Biol Endocrinol 2: 3, 2004.